Daily non-political popular news in brief.

HIV drugs, Abacavir and Didanosine increase the risk of heart attack

A study to assess the adverse effects of anti-retroviral drugsshows that two widely-used HIV drugs are associated withan increased risk of heart attack/the formation of blood clots inthe heart. With the use of Didanosine, the risk of developing aheart attack increases by 49 percent; with Abacavir, the increased riskis 90 percent. The effect is most pronounced in patients with a highunderlying cardiovascular risk.

Read more »

Keywords: hiv, drugs, abacavir, didanosine, risk, heart, attack, drug

« Previous | Next »

Similar news on "HIV drugs, Abacavir and Didanosine increase the risk of heart attack":

1. AHA statement recommends doctors change approach
   02-26-2007 · EurekAlert!
   Many doctors should change the way they prescribe pain relievers for chronic pain in patients with or at risk for heart disease based on accumulated evidence that nonsteroidal anti-inflammatory drugs (NSAIDs), with the exception of aspirin, increase risk for heart attack and stroke, according to an American Heart Association statement published today in Circulation: Journal of the American Heart Association.
   Similar news · Read more »
   
2. Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
   01-22-2007 · EurekAlert!
   Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
   Similar news · Read more »
   
3. High-dose anticlotting drug cuts heart attack, death risk in half
   05-11-2007 · EurekAlert!
   Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
   Similar news · Read more »
   
4. Use of diabetes medication by older adults linked with increased risk of heart problems, death
   12-11-2007 · EurekAlert!
   Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the Dec. 12 issue of JAMA. The authors suggest that these results provide further evidence that this class of medication may cause more harm than good.
   Similar news · Read more »
   
5. Drug does not reduce risk of death for heart attack patients with refractory shock
   03-26-2007 · EurekAlert!
   The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
   Similar news · Read more »
   
6. New strategy to cut heart attack risk is effective in initial test
   12-17-2007 · EurekAlert!
   The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
   Similar news · Read more »
   
7. HIV infection appears to increases the risk of heart attack
   04-24-2007 · EurekAlert!
   Researchers from Massachusetts General Hospital have found that infection with HIV, the virus that causes AIDS, is also associated with increased risk of myocardial infarction or heart attack. While rates of several cardiovascular risk factors were also increased in study participants infected with HIV, the increased incidence of heart attack was beyond what could be explained by risk factor differences.
   Similar news · Read more »
   
8. Long-term use of diabetes drug increases heart attack risk by more than 40 percent
   09-11-2007 · EurekAlert!
   An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.
   Similar news · Read more »
   
9. Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
   04-24-2007 · EurekAlert!
   The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
   Similar news · Read more »
   
10. Enzyme structure reveals new drug targets for cancer and other diseases
    02-14-2008 · EurekAlert!
    Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
    Similar news · Read more »